Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hendifar

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Gastro Hep Advances|August 12, 2024
COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United StatesBhupinder Kaur, Yee Hui Yeo, Jeff Liang, et al.
JAMA Network Open|December 10, 2021
A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric CancerEric Anderson, Alexis LeVee, Sungjin Kim, et al.
Cancers|February 11, 2023
Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000-2018Jamil S Samaan, Yazan Abboud, Janice Oh, et al.
World Journal of Gastrointestinal Oncology|March 23, 2022
Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancerLauren Midthun, Sungjin Kim, Andrew Hendifar, et al.
Hepatology (Baltimore, Md.)|April 16, 2022
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United StatesJoseph C Ahn, Marie Lauzon, Michael Luu, et al.
Oncotarget|November 16, 2017
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiativeMichael J Pishvaian, R Joseph Bender, Lynn M Matrisian, et al.
Cancers|January 8, 2023
Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic <i>MSH2</i> and <i>MSH6</i> Lynch Syndrome (LS) and an Instance of Recombinational Rescue from LSIngrid P Vogelaar, Stephanie Greer, Fan Wang, et al.
The Lancet. Oncology|March 6, 2020
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trialMichael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
JCO Precision Oncology|February 1, 2022
Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor ProgramMichael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
Cell Reports. Medicine|April 12, 2023
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancerVivek Nimgaonkar, Viswesh Krishna, Vrishab Krishna, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Gastro Hep Advances|August 12, 2024
COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United StatesBhupinder Kaur, Yee Hui Yeo, Jeff Liang, et al.
JAMA Network Open|December 10, 2021
A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric CancerEric Anderson, Alexis LeVee, Sungjin Kim, et al.
Cancers|February 11, 2023
Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000-2018Jamil S Samaan, Yazan Abboud, Janice Oh, et al.
World Journal of Gastrointestinal Oncology|March 23, 2022
Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancerLauren Midthun, Sungjin Kim, Andrew Hendifar, et al.
Hepatology (Baltimore, Md.)|April 16, 2022
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United StatesJoseph C Ahn, Marie Lauzon, Michael Luu, et al.
Oncotarget|November 16, 2017
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiativeMichael J Pishvaian, R Joseph Bender, Lynn M Matrisian, et al.
Cancers|January 8, 2023
Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic <i>MSH2</i> and <i>MSH6</i> Lynch Syndrome (LS) and an Instance of Recombinational Rescue from LSIngrid P Vogelaar, Stephanie Greer, Fan Wang, et al.
The Lancet. Oncology|March 6, 2020
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trialMichael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
JCO Precision Oncology|February 1, 2022
Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor ProgramMichael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
Cell Reports. Medicine|April 12, 2023
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancerVivek Nimgaonkar, Viswesh Krishna, Vrishab Krishna, et al.
Pageof 9